🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Experimental Treatment Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Followers are encouraged to message these accounts directly for supplier links, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with thousands of members share comparison photos, injection guides and claims of next-day UK delivery. Sellers promote the drug there before directing customers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Experts Voice Worries

Nevertheless, doctors and pharmacists have cautions that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could result in individuals injecting substances of unknown origin.

Some experts said the demand for the experimental drug could be connected to the increasing price of licensed slimming products such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be promoted or supplied for human use under the British medical regulations.

Several content creators attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate pharmaceutical, advertising, and consumer laws, risking fines, legal action or prison.

Service Response and Content Removal

According to TikTok, the service has removed problematic material and prohibited associated keywords and search suggestions. The company stated it was dedicated to maintaining the service safe and investing in strengthening compliance measures.

Online Trading Activities

Investigations also found communities with up to 9,000 participants marketing retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly displays channels with thousands of users, filled with photos of slimming results, positive reviews and step-by-step guides for preparing or injecting at home.

After minutes of joining one group, a vendor shared WhatsApp details, where most transactions take place. The vendor provided an guidebook and promised shipping within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about body mass, health issues or previous experience.

Product Information and Costs

Inside these communities, messages display dark colored parcels with postal service stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with sterile water, or pre-filled pens typically sold at 160 pounds for 20 milligrams. When questioned how long a pen should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A representative for Telegram stated it regularly monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting materials they can’t verify. Although the science behind retatrutide is valid, these online products may not include what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, patients are using social media. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her team has previously encountered patients harmed by self-injection from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a company investigational substance not yet authorized … may subject patients to potentially serious health risks”.